Skip to main content

Table 2 Levels of traditional and candidate markers in studied groups

From: Diagnostic performances of leucine-rich α-2-glycoprotein 1 and stem cell factor for diagnosis and follow-up of colorectal cancer

Study groups

CEA (ng/ml)

CA19.9 (μ/ml)

PLR

SCF (ng/ml)

LRG1 (μg/ml)

SCF-LRG1 (μg/ml)

Healthy subjects

43.1 ± 14.0

98.1 ± 32.2

4.8 ± 2.2

231.9 ± 33.2

39.6 ± 16.3

3.1 ± 0.64

Benign

88.8 ± 21.8

118.7 ± 37.5

5.2 ± 2.3

440.1 ± 35.4

44.6 ± 8.7

3.6 ± 0.38

CRC

47.7 ± 13.5

108.5 ± 34.2

5.0 ± 2.2

605.7 ± 38.5

52.5 ± 16.9

4.6 ± 1.3

p value a

0.349

0.216

0.025

0.001

0.0001

0.0001

Non-treated CRC

40.1 ± 33.7

155.9 ± 49.3

6.2 ± 2.1

1185.3 ± 39.5

69.3 ± 12.0

5.3 ± 1.6

Treated CRC

26.0 ± 22.2

68.6 ± 48.3

4.2 ± 1.9

530.2 ± 39.1

54.2 ± 13.2

4.0 ± 0.59

p valueb

0.978

0.167

0.014

0.019

0.001

0.001

  1. aFor discriminating among studied groups
  2. bFor discriminating between non-treated and treated CRC groups